|
業務類別
|
Biotechnology |
|
業務概覽
|
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer. |
| 公司地址
| 701 Tillery Street No. 12, No.1010, Austin, TX, USA, 78702 |
| 電話號碼
| +1 240 243-8000 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.faeththerapeutics.com |
| 員工數量
| 29 |
| Mr. Patrick Gallagher |
Chief Business Officer |
-- |
15/06/2023 |
| Ms. Erin Colgan |
Chief Financial Officer and Principal Accounting Officer |
美元 410.00K |
29/02/2024 |
| Mr. Anand Kiran Parikh |
Director and Chief Operating Officer |
-- |
18/02/2026 |
| Mr. Edward Van der Horst, PhD |
Chief Scientific Officer |
美元 400.00K |
11/04/2025 |
| Dr. Robert Pierce |
Chief Research and Development Officer |
美元 410.00K |
28/04/2022 |
| Ms. Marie-Louise Fjaellskog |
Chief Medical Officer |
-- |
30/03/2021 |
| Mr. Christopher W Gerry |
President, Principal Executive Officer and General Counsel |
美元 398.18K |
16/04/2026 |
| Ms. Stephanie Krebs |
Chief Business Officer |
美元 385.00K |
11/04/2025 |
| Mr. John Celebi |
President, Chief Executive Officer and Director |
美元 535.60K |
11/04/2025 |
| Mr. Josiah Craver |
Senior Vice President, Finance, Principal Financial Officer and Principal Accounting Officer |
美元 372.65K |
27/04/2026 |
| Dr. Brian C. Stephenson, PhD |
Chief Financial Officer |
-- |
10/06/2026 |
|
|
| Mr. William R. Ringo, Jr |
Chairman of the Board |
11/04/2025 |
| Dr. Deneen Vojta, M.D. |
Independent Director |
30/10/2024 |
| Mr. Anand Kiran Parikh |
Director and Chief Operating Officer |
18/02/2026 |
| Dr. Jessie M. English, PhD |
Independent Director |
27/06/2024 |
| Dr. Samuel Broder,M.D. |
Independent Director |
15/06/2023 |
| Ms. Saira Ramasastry |
Independent Director |
16/04/2026 |
| Mr. Thomas G. Ricks |
Independent Director |
16/04/2026 |
| Mr. Stephen M. Hahn |
Independent Director |
16/04/2026 |
| Mr. Bob Holmen |
Chairman of the Board |
27/04/2026 |
| Mr. Kristian F. Humer |
Independent Director |
16/04/2026 |
| Mr. John Celebi |
President, Chief Executive Officer and Director |
11/04/2025 |
| Mr. Phillip B. Donenberg |
Director |
13/02/2026 |
| Dr. James Peyer, PhD |
Independent Director |
11/04/2025 |
| Dr. Karen H. Vousden, PhD |
Independent Director |
10/06/2026 |
|
|
|
|